Portfolio company
BioSapien
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops 3D-printed biodegradable mesh for localized and sustained delivery of chemotherapy drugs to cancer patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Brinter
This company develops 3D-bioprinted regenerative medical implants for healthcare providers to treat patients requiring breast reconstruction and orthopedic repairs.
Cebiotex
This company develops nanofiber membranes that release anti-tumour agents at surgical sites for oncology patients.
Carcinotech
Carcinotech manufactures 3D-bioprinted, patient-derived tumour models for drug developers and oncologists to perform rapid and ethical cancer drug testing and personalised medicine.
Iscaff Pharma
This company develops patient-derived tumor scaffolds for pharmaceutical firms to improve the pre-clinical validation and development of aggressive cancer treatments.
NaDeNo
This company develops a nanotechnology drug delivery platform for pharmaceutical partners to encapsulate hydrophobic small molecule drugs for targeted cancer treatments.
LEUKO
This company develops a non-invasive device for monitoring white blood cell levels at home for cancer patients undergoing chemotherapy.
FemTherapeutics
This company produces custom-fit 3D-printed gynecological prosthetics for women suffering from pelvic floor disorders such as prolapse and incontinence.
PRINTYMED
This company produces biomimetic spider silk materials for medical researchers, healthcare providers, and cosmetic manufacturers to enable regenerative treatments and sustainable product formulations.